## **REGISTERED CHARITY NUMBER: 1188749 Report of the Trustees and Unaudited Financial Statements for the period 1 January 2025 to 31 December 2025 ST FRANCIS LEPROSY GUILD**
1
## **Contents**
|**Contents**||
|---|---|
|Board of Trustees|03|
|About leprosy - a curable disease|06|
|St Francis Leprosy Guild (SFLG)|07|
|Vision, Mission and Values|08|
|Objectives and aims|09|
|Operational activities|09|
|Fundraising and performance|14|
|Structure, governance, and management|19|
|Independent examiner’s report|21|
|Financial Statements|22|
## **Abbreviations**
**CRM** Customer Relationship Management (database) **CBCEW** Catholic Bishops’ Conference of England and Wales **CIO** Charitable Incorporated Organisation **GDPR** General Data Protection Regulation **LSHTM** London School of Hygiene & Tropical Medicine **NGO** Non-Governmental Organisation **SFLG** St Francis Leprosy Guild **WHO** World Health Organization
2
St Francis Leprosy Guild Annual Report and Accounts 2025
## **Reference and administrative details for the year 01 January 2025 to 31 December 2025**
The trustees present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice, applicable to charities preparing their accounts. This is in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland.
## **Board of Trustees**
Mr Edward Reed (Chair of Trustees)
Mrs Clare Barton (Vice Chair)
Mrs Caroline Connolly-Newland (Treasurer) (resigned October 2025)
Fr Gary Dench (Spiritual Director) (appointed July 2025)
Mr Liam Allmark (former CBCEW representative) (resigned October 2025)
Dr Aodhán Breathnach (appointed October 2025)
Ms Molly Conrad (CBCEW representative) (appointed May 2025)
Dr William Dibb (resigned May 2025)
Professor Noel Gill
Dr Donal O’Sullivan
Ms Sandra Pearce (resigned October 2025)
## **Director**
Mrs Katharine Jones
3
St Francis Leprosy Guild Annual Report 2025
Brief details about the current trustees are as follows:
**Chair, Edward Reed.** Edward is a solicitor and Senior Advisor at Macfarlanes. Having been at Macfarlanes for over 30 years and a partner there for 22 years, he stepped down in April 2025 to focus on key client relationships. He advises internationally mobile families on their asset structuring, personal tax, estate and succession planning, wills, charity and trusts. He has an affinity for civil law and private international law issues.
**Vice Chair, Clare Barton.** Clare is a retired solicitor whose career included working for a major City law firm and as an in-house lawyer. She has done a range of voluntary roles, including being a school governor for many years. **She is joint Safeguarding Lead for SFLG** .
**Spiritual Director, Fr Gary Dench** . Fr Gary trained for the priesthood at the Venerable English College, Rome, and was ordained in 2019. He served for five years as the Assistant Priest at Brentwood Cathedral and is presently the Parish Priest of Hutton & Shenfield in Essex. He studied Canon Law through the Catholic University of Leuven and works in the diocesan curia as the Diocesan Master of Ceremonies, Director of Liturgy and Vice-Chancellor.
> **Dr Aodhán Breathnach.** Aodhán is a doctor who worked for many years in St George’s Hospital, London, specialising in Medical Microbiology and Infection Control. He was also a member of the St George’s Hospital Clinical Ethics Committee, and more recently he worked as a Global Health Microbiologist with the United Kingdom Health Security Agency.
**Molly Conrad.** Molly is Senior Consultant for Public Affairs at the social justice and faith-based consultancy, The Good Faith Partnership. Prior to joining Good Faith, Molly worked for CBCEW in their Partnerships & Public Affairs Department. Molly is passionate about building meaningful and sustainable partnerships between parliamentarians, charitable foundations and faith communities to ensure that grassroots experts and people of faith have a voice in top-level decision-making processes.
> **Professor Noel Gill.** Noel is an infectious disease epidemiologist and honorary professor at LSHTM. He worked at Public Health England’s National Infectious Disease Surveillance Centre leading the HIV & STI team 1980 to 2020. After retirement he returned part-time from 2020 to 2021 to assist with the response to the COVID-19 emergency.
> **Dr Donal O’Sullivan.** Donal has worked for almost forty years in Southeast London, first as a Consultant in Communicable Disease Control, and more recently as a Consultant in Public Health. Donal currently teaches on the Master of Public Health course at King's College London. **He is joint Safeguarding Lead for SFLG.**
4
St Francis Leprosy Guild Annual Report 2025
## **Principal address**
## **(up to 31 March 2025):**
73 St Charles Square London W10 6EJ
## **(from 1 April 2025):**
51 High Street Arundel West Sussex BN18 9AJ
Registered charity number: 1188749
## **Independent examiner**
PKW Accountants Limited Second Floor 1 Church Square Leighton Buzzard Bedfordshire LU71AE
## **Bankers**
CAF Bank Limited Kings Hill West Malling Kent ME19 4TA
Barclays Bank 1 Churchill Place London E14 5HP
## **Accountants**
Waugh & Co Licensed Accountants 51 High Street Arundel West Sussex BN18 9AJ
5
St Francis Leprosy Guild Annual Report 2025
## **About leprosy – a curable disease**
Leprosy, also known as Hansen’s disease, is a chronic, infectious disease caused by the bacterium _Mycobacterium leprae_ . Leprosy affects the skin, peripheral nerves and the upper respiratory tract. Leprosy can affect anyone, at any age, but it is linked to poverty and malnutrition.
Despite the widespread fear that leprosy is highly contagious, it is in fact difficult to catch and 95% of us are resistant to developing the disease. It is thought that leprosy is spread by droplet infection (coughing and sneezing) during prolonged and close contact with untreated individuals who have the disease. People who lack access to clean water, sanitation and hygiene, those with compromised immune systems or who are malnourished are also more likely to catch it. Leprosy is a disease of poverty and continues to be a public health challenge in low and middle-income countries.
Leprosy is difficult to diagnose, especially in the initial stages. It attacks peripheral nerves, which destroys the ability to feel pain. The lack of sensation leads to trauma, ulcers and other localised infections. Left untreated, these infections can lead to permanent disability, disfigurement and amputations. Even those treated for leprosy and who are no longer infectious can still develop complications over their lifetime. Leprosy can also cause blindness, facial disfigurement and the clawing of hands and feet. The visible disability and disfigurement caused by leprosy over the years means the disease is greatly feared. Many leprosy-affected people (including their families and children) are subjected to stigma and discrimination and excluded from society. Since the earliest of times, fear and ignorance have meant society discriminates against and denies leprosy-affected people their right to a full and normal life.
In addition, outdated discriminatory laws often mean that people with leprosy can be forcibly evicted from their homes, livelihoods, and places of work. In some parts of the world, leprosy can form grounds for divorce. Due to these terrible injustices, people with leprosy may not come forward for medical treatment, putting themselves, their families and communities at greater risk. A United Nations Special Rapporteur (operating under the aegis of the UN High Commissioner for Human Rights) is working to identify and repeal these laws.
## **Leprosy is curable today with a combination of antibiotics known as Multidrug Therapy (MDT) which first became available in 1981. MDT has been distributed free of charge worldwide to patients since 1991.**
Following the introduction of MDT, around seventeen million people have been released from treatment for leprosy. However, since the early 2000s, the downwards trend of numbers diagnosed and treated has stagnated at around 200,000 per year. In addition, the number of people contracting the disease who are undiagnosed, or living with its effects, such as blindness, amputated limbs or the stigma and discrimination associated with it, is many millions.
The WHO monitors leprosy worldwide and has developed a global leprosy strategy, which is reviewed by experts every five years. The goal of the current strategy is to achieve Zero Leprosy, which is a long-term vision of _zero infection and disease, zero disability, zero stigma and discrimination_ **.** The medium-term goal is the _elimination of leprosy, defined as interruption of transmission_ . SFLG, along with the rest of the global leprosy community, is aligned with the WHO strategy. The final mile to ending leprosy is proving to be the toughest and most challenging. According to WHO, there are between two and five million undiagnosed leprosy-affected people worldwide. So, although we can see an end to this terrible and ancient disease, there remains plenty to be done to achieve Zero Leprosy. It is this ongoing challenge which keeps SFLG focused.
6
St Francis Leprosy Guild Annual Report 2025
## **St Francis Leprosy Guild (SFLG)**
SFLG was founded on 23 October 1895. The moving spirit was Kate Marsden, a nurse who was determined to relieve the desperate plight of people affected by leprosy throughout the world. Until a cure for leprosy became widely available through the WHO in the 1980s, SFLG’s primary activity was the compassionate support of leprosy villages, hospitals, clinics or communities that treat or care for people with leprosy and their dependants.
In 2017, SFLG embarked on “A Pilgrimage of Hope” combining a commitment to play our part in the WHO’s developing strategies, currently (2021-30) “Towards Zero Leprosy” with a determination to increase the charity’s professionalism and grow the voluntary income needed to meet that challenge.
As part of that process, SFLG became a Charitable Incorporated Organisation (CIO) in 2020. SFLG’s key strategic focus is now the detection and diagnosis of people with leprosy as early as possible, while maintaining the material support that it has provided to people affected by leprosy and their dependants. SFLG’s activities and projects, particularly its focused, intensive Active Case-Finding programme, are now making an important contribution to stopping the disease in its tracks and preventing lives from being destroyed by ascertaining, diagnosing, treating, and rehabilitating people with leprosy. In addition, through its membership of the Leprosy Research Initiative, SFLG has contributed towards innovative applied research projects.
SFLG is a member of ILEP (The International Federation of Anti-Leprosy Associations) through which SFLG has a direct relationship with the relevant WHO and UN policy.
**SFLG is the UK’s Catholic leprosy charity.** Although a Roman Catholic charity, SFLG has never made any distinction regarding the creed or denomination of our beneficiaries, nor of race, skin colour, gender or age. We are proud of our heritage and, conscious of the trust our benefactors and donors have placed in us, we are invigorated by the unique opportunity we have before us to play our part in ending leprosy for good.
On 4 October 2025, SFLG celebrated 130 years in operation and held its Annual Mass in Westminster Cathedral. During his homily, the Celebrant, the Right Reverend James Curry, Auxiliary Bishop of Westminster commended our work and prayed for people affected by leprosy and those who care for them. In 2025, SFLG also celebrated the Catholic Jubilee and the major Franciscan anniversaries including the 800th anniversary of the Canticle of the Creatures. SFLG will be commemorating the 800th anniversary of the death of its patron saint, St Francis of Assisi in 2026.
7
St Francis Leprosy Guild Annual Report 2025
## **Vision, Mission and Values**
Our **Vision** is a leprosy-free world.
Our **Mission** is to end leprosy's devastating impact everywhere for everyone.
Our **Values** align with the Five Franciscan Values:
1. **Service** - to serve others, especially the most vulnerable.
2. **Respect for creation** - to honour all creation, especially ourselves and each other.
3. **Reverence** - to approach God and all creation in wonder and awe.
4. **Peace and justice** - to strive for a world where all people can live in peace and dignity.
5. **Humility** - to recognise our need of God, our dependence on God and our need for each other.
To achieve our vision and mission, we work with dedicated partners around the world:
- to help find and cure people with leprosy before they develop disabilities;
- to care for people living with leprosy's devastating impact, and
- to fund research into new ways to end leprosy.
In 2025, SFLG worked in eleven countries supporting thirty centres and partners.
Where we work in Africa
Where we work in Brazil
Where we work in Asia
8
St Francis Leprosy Guild Annual Report 2025
## **Objectives and aims**
SFLG’s objectives are as follows:
1. funding organisations giving relief and assistance to persons with leprosy or disabled as a result of leprosy, their families and dependants throughout the world;
2. funding activity towards prevention and control of the disease of leprosy, including relevant investigations and research of the causes, treatment and prevention of this disease, and
3. carrying out or funding the professional education of those engaged in the prevention, diagnosis and treatment of leprosy.
In our activities as described below, the trustees consider that they have complied with their duty to have due regard to the guidance issued by the Charity Commission, including on public benefit.
## **Operational activities**
## **Partnership Management**
SFLG builds and maintains partnerships through diverse channels, including direct inquiries, responses to calls for proposals, and referrals from trusted local stakeholders. To ensure alignment with its mission, SFLG selects partners carefully based on strict criteria, including strong governance, a clear focus on leprosy-related work, regulatory compliance, sound financial practices, and a demonstrated commitment to patient care and safeguarding. Once partnerships are established, SFLG maintains exacting standards of accountability and impact through robust monitoring and evaluation methods. This approach includes regular financial audits, site visits and consistent reporting, ensuring effective use of donor funds and meaningful support for individuals affected by leprosy.
In 2025, St Francis Leprosy Guild strengthened its partnerships in Uganda through on-site evaluations of two key healthcare providers, St Francis Hospital Buluba and St Francis Hospital Nyenga. These visits confirmed the partners’ commitment to delivering comprehensive, patient-centred leprosy care, while also identifying areas for further support. The insights gained enabled SFLG to refine its project application and reporting tools, ensuring more accurate and relevant data collection. This work has enhanced our ability to monitor projects effectively, improve accountability, and align our support with partner needs, advancing our mission to reduce the burden of leprosy and support affected communities.
9
St Francis Leprosy Guild Annual Report 2025
## **Operational Strategy**
In 2025, SFLG continued to categorise its operating activities under the **TRACE** acronym.
|**Training**|Supporting undergraduate and postgraduate leprosy-specific specialist
skills through short or long-term training and learning opportunities for any
grade of healthcare worker to develop their potential as future specialist
leaders committed to Zero Leprosy.|
|---|---|
|**Research**|Supporting applied research into leprosy transmission, prevention, and care (in
collaboration with the Leprosy Research Initiative).|
|**Active Case-Finding**|Detecting new leprosy cases by screening all members of at-risk populations.|
|**Care**|Supporting the care of people affected by leprosy and their contacts by
providing inpatient and outpatient treatment, surgery, rehabilitation, and long-
term care for people diagnosed with leprosy, their families, and others living in
or near their households.|
|**Emergency**
**Support/Equipment**|Investing capital in leprosy-related equipment, maintenance of facilities and
rebuilding. Maintaining an Emergencies Reserve to meet any needs that may
arise due to adversity.|
## **Training**
It is difficult to recruit healthcare practitioners to work in a highly stigmatised disease area like leprosy. Leprosy treatment lacks the prestige and higher salaries of many medical disciplines. Our aim is to support opportunities to fill this deficiency gap and increase the leprosy care experience of healthcare professionals. For this reason, funding leprosy-specific training for healthcare professionals is part of SFLG's activity.
In 2025, training was carried out for healthcare staff and community outreach workers through our Care and Active Case-Finding projects, focusing on spotting the early signs of leprosy.
## **Research**
SFLG is an Associate Member of the Leprosy Research Initiative (LRI), a global joint venture of twelve leprosy NGOs with the shared goal of working together to achieve Zero Leprosy. LRI consolidates leprosy research worldwide and prioritises future projects to deliver the vision of a world free from leprosy. SFLG’s membership of LRI ensures our research investment is distributed competitively, is independently peer-reviewed, and is expertly evaluated.
SFLG is funding two significant projects through this relationship:
1. In India and Nigeria, we are supporting "Capacity Building for Leprosy" (CapaBLe), a research project aimed at strengthening healthcare workers' expertise through a blended learning approach. This research seeks to assess the impact of combining online and face-to-face training on the knowledge, skills and performance of health workers managing leprosy. By developing evidence-based, sustainable training models, the project aims to enhance early detection, treatment and care for those affected by leprosy, contributing to global efforts to eliminate the disease.
2. In India and Nepal, we are supporting the initiative _"Working Towards Mental Health Recovery Among_
10
St Francis Leprosy Guild Annual Report 2025
> _Persons Affected by Leprosy."_ This study seeks to enhance the lives of individuals affected by leprosy who are experiencing mental health challenges. By fostering empowerment and collaboration, it aims to develop locally grounded, meaningful and effective interventions.
The way we contribute to the LRI changed in 2025. In previous years, SFLG has contributed to a small number of specific research projects. We are now contributing towards the entire LRI portfolio, meaning SFLG’s funding will be deployed across more projects, maximizing donors’ impact.
## **Active Case-Finding**
Leprosy is a highly stigmatised, insidious, transmissible disease. It has an incubation phase of three to twenty years making its transmission almost impossible to trace. Leprosy may not cause any pain and discomfort in the initial stages, so people do not seek medical help. Once it is apparent, stigma or legal consequences frequently act as a powerful disincentive to seeking treatment. Yet early diagnosis and treatment would prevent the disability, stigma and disfiguration that can develop, and it would prevent others catching it.
To work towards the goal of Zero Leprosy, in 2020 SFLG began supporting selected partners to detect new cases of leprosy early by conducting door-to-door screening of all members living in disadvantaged populations who are at a higher risk of leprosy. The aim of this population-based Active Case-Finding (PB-ACF) programme is to screen all members of a target population over a three-year period, through a series of case-finding campaigns in local areas where the incidence of leprosy may be high.
In its initial phase, SFLG supported nine community-based organisations, who specialise in leprosy services and community outreach, in delivering our PB-ACF programme.
These initial projects met with considerable success in finding people living with undiagnosed leprosy, who were then able to receive treatment.
The conclusion of SFLG’s first PB-ACF projects provided a valuable opportunity for our programmes team, partners and technical advisors to reflect on the results before shaping the next phase of our work. This period of learning and evaluation was essential, helping us to understand which approaches are most effective, where interventions have the greatest impact, and how we can best support our partners in reaching people affected by leprosy.
Building on this work, in 2025 SFLG invited partners to propose new PB-ACF projects. SFLG agreed to support three more projects, which will run from 2025 to 2027 in the following areas:
1. Mumbai, India (Alert India)
2. Abakaliki, Nigeria (St Patrick’s Mile Four Hospital), and
3. Dinajpur, Bangladesh (Dhanjuri Leprosy Project).
In July 2025, the director and the Programmes Manager participated in the 22nd International Leprosy Congress in Bali, Indonesia. Abstracts were presented on our ACF data highlighting 803,041 screenings, 519 people diagnosed with leprosy and 260 people trained to diagnose leprosy. The Board was delighted that we had the opportunity to present our ACF data to this international audience.
## **Care**
SFLG's principal activity since 1895 has been supporting treatment and rehabilitation for people with leprosy, together with awareness campaigns to combat stigma and remove the fear and misunderstanding surrounding the disease. Leprosy-affected individuals require a range of support
11
St Francis Leprosy Guild Annual Report 2025
including reconstructive surgery, physiotherapy, social rehabilitation and training in new skills, and, in some cases (where individuals have been rejected by their communities), lifelong care is needed. SFLG supports the holistic care of people affected by leprosy and their contacts through the provision of inpatient and outpatient treatment and care. Our partners include hospitals, clinics, leprosy villages and community-based rehabilitation organisations.
In 2025, SFLG supported twenty-five partner organisations in eleven countries reaching 31,858 people through care-focused interventions. The objective of all these interventions is to enable people affected by leprosy to return to their communities and make their contribution to their family life and society. In addition, our partners diagnosed 1,895 new cases of leprosy in 2025.
Some of SFLG's key projects include:
- Continuing our long-standing partnership with the Sisters of Our Lady of the Mission in Myanmar to ensure that elderly leprosy patients are not forgotten, providing them with essential supplies and access to critical healthcare.
- Expanding our support for Dr Tony Gonzalez and her hospital boat, which brings vital healthcare, leprosy testing and treatment to remote communities along a tributary of the Amazon River that cannot be reached by road.
- Partnering with International Nepal Federation at Green Pastures Hospital in Nepal to provide life-changing medical support, as well as self-care groups, medication assistance and rehabilitation for people affected by leprosy.
- Funding and supporting St Francis Hospital in Nyenga, Uganda, which delivers lifesaving treatment, care and surgery for leprosy patients, while also helping them to recover and reintegrate into their communities.
## **Emergency Support/Equipment**
We maintain an Emergencies Reserve to enable us to respond quickly to crises such as natural disasters that impact on our partners or people affected by leprosy. In 2025, SFLG provided critical support to Aripea Health Centre in Uganda after concerns were raised that the poor living conditions of a resident affected by leprosy were judged to be harming her recovery and providing a significant risk to her long-term health. SFLG provided funds to support the immediate construction of a new home for the resident, who has since moved in and is recovering well.
## **Expenditure by TRACE (unaudited) 2025**
We aim to increase our TRACE expenditure every year. In 2025, we were able to increase our TRACE expenditure spent on Research, Active-Case-Finding and Care but our expenditure on Training and Emergency Support/Equipment was reduced. Our total TRACE expenditure was £264,220 in 2025 (from £268,567 in 2024).
12
St Francis Leprosy Guild Annual Report 2025
**----- Start of picture text -----**
TRACE expenditure 2024 2025
Training £500 £00
Research £40,000 £60,000
Active-Case Funding £30,264 £45,000
Care £140,000 £155,820
Emergency or Equipment £57,633 £3,400
Total £268,567 £264,220
**----- End of picture text -----**
## **Partner Due Diligence**
SFLG's Executive team carries out due diligence on our partners to ensure:
- the identity of the beneficiary
- that funds are applied in accordance with SFLG's charitable purposes
- that funds are not knowingly used for:
- money laundering, in accordance with the operative Anti-Money Laundering (AML) regulations governed by the Proceeds of Crime Act 2002 (POCA)
- terrorism financing, in accordance with the Terrorism Act 2000
- bribery, in accordance with the Bribery Act 2010.
SFLG's Executive team also adopts a risk-rated approach to due diligence. Risk factors include:
- funding contributed
- the country of residence of the recipient
- the geographical location in which the funding will be applied
- the nature of the relationship between the charity and the applicant
- the capacity of the partner organisations.
The results of any due diligence do not last indefinitely. In cases where beneficiaries are supported for a significant period, additional due diligence is undertaken if there is a change of circumstances that might impact the partner or, in any case, every two years.
13
St Francis Leprosy Guild Annual Report 2025
## **Fundraising and performance**
In 2025, SFLG generated a total income of £237,201 compared to £375,515 raised in 2024. A generous one-off donation made in 2024 had significantly increased that year’s income. The combination of reduced legacy and trust income in 2025 and the challenging fundraising environment for small charities meant that 2025 was a poorer year for fundraising in comparison to previous years.
In 2025, aware of the necessity to reduce our reliance on legacy income, we continued to focus our fundraising efforts on direct mail appeals, fundraising from trusts and some new initiatives including the Big Give. The trustees also approved the part-time engagement of a professional fundraiser and copywriter who could also build our social media presence online.
Conscious of the need to use publicity to promote awareness of leprosy and of SFLG within the Catholic community, we pitched and placed editorial articles in _Oremus_ (a magazine published by Westminster Cathedral) and the Catholic Union Weekly Briefing. The Tablet also featured an interview with SFLG’s Director, Katharine Jones, about leprosy and SFLG.
**Donor acquisition initiative – Parish Outreach** In 2025, it became clear from the reduced income raised from our appeals and from individual donors that our donor base was declining. Although “donor acquisition” has always been part of our fundraising agenda, we needed to amplify these activities. Despite receiving loyal support from some parishes, SFLG has over time become less widely known within the Catholic Church, and other leprosy charities are often better known. There was, therefore, a clear rationale to raise the profile of SFLG within the Catholic Church as **the UK’s only Catholic leprosy charity,** with the aim of securing new donors. To this end, we embarked on a “Parish Outreach” initiative, which entailed the development of a bespoke database containing contact details of over 1,500 Catholic churches and parishes in England and Wales to which we sent postal and digital communications about SFLG. A digital initiative for parishes has continued into 2026.
## TOTAL INCOME for 2025 - £237,201
## **Individual giving (donations and Gift Aid)**
SFLG issued six direct mail appeals in 2025: Spring (including a Spring newsletter), Easter, Summer (“The Lost Children of Leprosy”), Annual Review 2024, Autumn (including the Autumn Newsletter), and a Christmas appeal in support of general funds. All our direct mail appeals are mirrored on the website and supported by our social media. These appeals were well-supported, and we experienced increased fundraising through the website corresponding to the times of the appeals.
We also receive donations in the form of regular giving every month or year. Some donors have been
14
St Francis Leprosy Guild Annual Report 2025
exceptionally generous in 2025. To these donors and all our donors, we offer our thanks. Donations from direct mail and regular giving decreased in 2025 to £136,185 from £219,030 in 2024. Within the amount is £7,639 which relates to Big Give below.
## **Legacies**
SFLG was fortunate to receive generous support from its benefactors. In 2025, SFLG received five legacies totalling £67,812 (compared with £97,967 in 2024).
The details of SFLG’s legators are captured in a Book of Remembrance and prayed for regularly. In addition, the names of legators are recorded in SFLG’s online Garden of Remembrance.
## **Trusts**
Fundraising from trusts continued in 2025. A professional fundraiser was engaged to drive our fundraising activities from trusts and foundations and build a pipeline of trust income. By the end of 2025, it was clear that, despite this work being tackled rigorously, fundraising from trusts with whom we do not have a relationship was not yielding sufficient funds to make the time spent on it viable. £10,520 was raised in 2025 compared with £35,950 in 2024. The proactive raising of funds from trusts was therefore discontinued in 2026.
## **Big Give**
In 2025, we took part in the Big Give, a UK-based charity and online fundraising platform that doubles donations to charity projects, allowing supporters to increase their impact. In terms of both fundraising and donor acquisition, our trial run for the Big Give was a success. We raised a total of £7,639 and secured several new donors.
## **Investment income**
Investment income decreased to £651 compared to £2,161 in 2024. The decrease was mainly due to less interest paid on reduced cash balances.
SFLG is registered with the Fundraising Regulator and complies with its standards. No complaints were received about any aspect of fundraising in the reporting period. SFLG is compliant with the GDPR in all its activities and no data is sold to other organisations.
## **Overview of other operations**
## **Annual Mass and Assembly**
The Annual Thanksgiving Mass and Assembly celebrating SFLG's 130th anniversary took place on 4 October 2025 at Westminster Cathedral, London, SW1, and afterwards at The Windsor Castle pub. The Mass was celebrated by the Right Reverend James Curry (Auxiliary Bishop for the Diocese of Westminster) and concelebrated by our Spiritual Director, Fr Gary Dench. The Annual Mass and Assembly is a great opportunity for SFLG’s trustees and team to meet and thank its supporters in person.
## **Volunteers**
SFLG is very privileged to have a committed, volunteer Board of Trustees, many of whom are leaders in their fields. Its trustees gave extensively of their time in 2025. The total value of the trustees’ time cannot be estimated under normal measures but by any assessment it is of considerable value.
15
St Francis Leprosy Guild Annual Report 2025
## **Director**
In May 2024, Katharine Jones was appointed Director. She remained in this role throughout 2025. She started working with St Francis Leprosy Guild in 2021.
## **Accountant**
In 2025, the trustees continued to outsource accounting to Waugh & Co Licensed Accountants. Edmund Chavasse MAAT of Waugh & Co has handled the charity’s day-to-day accounts since May 2023.
## **Data management, donor relationships and donor data**
Throughout 2025, an experienced bookkeeper (who was engaged in 2023) continued to manage the charity’s donor relationships, process all donations and update data on the CRM system, Donorfy. The trustees believe that high quality data handling, security and GDPR compliance are imperative. The trustees consider that our database of donors and contact details is a considerable asset. This approach contributes to the integrity of the charity’s data and strength of its donor relationships.
## **Social Media**
In 2025, to raise and increase the charity’s profile through its social media channels (Facebook, Instagram, LinkedIn and Twitter/X), the trustees engaged a social media expert to build our presence. In 2025, there was a particular focus on messaging that supported our Parish Outreach initiative.
## **Website**
The Director has developed the website since 2021 and uses the website to support SFLG’s fundraising and donor acquisition initiatives, illustrate our work and promote news and events.
## **Policy**
Throughout 2025, SFLG has continued to update its policies in line with Charity Commission best practices.
## **Executive team**
At the end of 2025, the charity had two full-time employees (Charlotte John, Programmes Manager, and Rosanna Threakall, Secretariat Manager) and a full-time Director. Part-time self-employed individuals carried out other operational requirements such as fundraising. The trustees would like to thank the Director and team for their hard work and commitment to the success of the charity in 2025.
## **Operating Costs**
SFLG pays close attention to the control, and, where possible, reduction, of its annual operating costs.
In 2025, the costs of employing staff (pension, taxes and wages) increased to £76,318 from £69,706 in 2024 due to the increases in National Insurance contributions.
In 2025, other operating costs (which comprised the Director’s fees, data management fees, legal and professional fees, and social media fees) decreased to £82,807 from £122,415 in 2024 due to lower data management fees.
16
St Francis Leprosy Guild Annual Report 2025
## **Office Closure, 73 Charles Square**
In early 2025, the trustees decided to reduce our operational costs by closing the office at 73, St Charles Square, London, W10. The office, which was rented from The Catholic Children’s Society, had been SFLG’s London base for many years. The trustees would like to thank The Catholic Children’s Society for being a generous and helpful landlord. SFLG’s registered office was moved, with effect from 1 April 2025, to 51 High Street, Arundel, West Sussex, care of our Accountant, Waugh & Co.
Closing the office yielded around 60 boxes of financial and administrative information, records, books, artifacts, pictures, statues, letters, and a wealth of photographs dating back to SFLG’s foundation in 1895. The trustees were pleased to relocate the historical archive to the Franciscan Missionaries of the Divine Motherhood (“FMDM”) based in Godalming. The trustees would like to thank the Congregational Leadership Team of the FMDM for providing a new home for our archive and the archivists who managed its relocation. The trustees are delighted that Kate Marsden’s legacy will be preserved for the long term.
## **Support costs**
Rent and utilities decreased to £1,118 in 2025 from £8,161 in 2024, due to the office closure. The cost involved in closing the office was £3,949 and records management £3,349. The insurance premium increased to £2,181 in 2025 from £2,114 in 2024.
UK travel costs increased to £12,561 in 2025 from £7,283 in 2024.
IT, software and website costs decreased to £5,315 in 2025 from £43,103 in 2024 (but digital platform costs increased to £3,165 in 2025 from £1,255 in 2024 reflecting our use of the Donorfy CRM for Parish Outreach).
Membership subscriptions decreased to £6,979 in 2025 from £8,656 in 2024.
TRACE-related travel to the 22[nd] International Leprosy Congress (where we presented our Active Case-Finding data) and to visit our centres in Uganda totalled £10,349 in 2025. This is part of the overall Travel figure of £12,561 (2024: £7,283).
These and other support costs totalled £188,755 in 2025 compared to £230,872 in 2024 _**.**_
## **Costs of generating voluntary income**
The costs of donor acquisition, maintaining our donor relationships, handling donations, fundraising and implementation decreased to £123,810 in 2025 from £124,365 in 2024.
## **SFLG’s future and Managed Contraction**
Despite considerable cuts made to expenditure in 2024 and 2025 alongside careful budgeting, it became increasingly apparent in 2025 that:
1. the number of donors is declining so funds raised from direct mail appeals and individual donations are declining
2. legacy income is declining year on year
3. unless significant legacies are received, current annual income will not cover the cost of current annual expenditure
4. bank balances and reserves would be exhausted by 2027 at current levels of expenditure.
Recognising that the fundraising environment is currently challenging for small charities and wishing to preserve SFLG’s ability to continue with its work for as long as possible, at the end of 2025 the
17
St Francis Leprosy Guild Annual Report 2025
trustees agreed to streamline and fine tune SFLG’s operations with a view to reducing its expenditure substantially.
Every item of expenditure was assessed, and budgets for 2026 have been stopped or reduced across many lines, including memberships, data management, administration, fundraising, social media, travel and TRACE (related to Training and Emergency Support/ Equipment). New budget has been allocated to donor acquisition and specifically to parish outreach. The outcome of this ‘Managed Contraction’ phase will be reported in the Annual Report for 2026.
## **Safeguarding**
SFLG’s employees have little direct contact with people with leprosy, vulnerable adults or children, but the prime purpose of the partner organisations it supports is the daily care of such people. The Board requires that all our partners comply with SFLG's Safeguarding Policy and Code of Conduct. All the partner organisations that SFLG worked with in 2025 confirmed in writing that they were in full compliance with both policies. Compliance with SFLG’s Safeguarding Policy and Code of Conduct will continue to be an absolute requirement for any future potential partner organisations. We continue to work closely with our partners to ensure safeguarding is prioritised and mainstreamed into our programmes and projects.
Our Joint Designated Safeguarding Leads in 2025 were Dr Donal O’Sullivan and Clare Barton.
## **Accounting practice**
These accounts have been prepared on an accrual basis.
## **Reserves policy**
As at 31 December 2025, SFLG held unrestricted reserves of £425,184 compared to £703,290 in 2024.
Trustees have reviewed the activities and commitments of the charity and determined that, to ensure continuity of activities and honour contractual liabilities, a level of free reserves should be maintained at between £250,000 and £500,000.
## **Investment policy and objectives**
The trustees are eager to generate a level of returns from reserves without taking on unacceptable risk. Their approach is to accept a level of medium risk, with a balance sought between realising a target income and achieving capital growth. Investments are divided among equities, bonds, cash and alternatives. The portfolio is externally managed by investment managers who are regulated by the Financial Conduct Authority. Updates on the value of the portfolio are provided to SFLG quarterly. At least once a year the Board discusses the performance of the investments with SFLG’s investment manager, as well as the prevailing and anticipated economic conditions and a forecast of future trends. Trustees review the level of risk annually and look at future cash requirements to be funded by the investments. In the implementation of this policy, the trustees follow the Charity Commission guidance for the investment of charitable funds.
Our Investment and Reserves Policy governs our funding strategy.
## **Asset management**
In 2025, Waverton Investment Management (which rebranded as W1M in June 2025) continued to manage SFLG’s investment portfolio (having taken over as investment managers in July 2024). Between 31 December 2024 (portfolio valued at £638,000) and 31 December 2025 (portfolio valued at £462,000) the amount withdrawn from the portfolio to fund our operations totalled £250,000 (yet
18
St Francis Leprosy Guild Annual Report 2025
the value of the portfolio decreased by only £176,000, as a result of investment growth on the underlying assets).
## **Risk assessment**
The trustees have assessed the major risks to which the charity is exposed, those related to the governance, operations and finances of SFLG, as well as those relating to the external economic environment and the regulatory framework in which SFLG operates. The trustees review these risks on a regular basis and are satisfied that systems are in place to mitigate exposure to major risks from within SFLG.
## **Structure, governance, and management**
The charity is controlled by its governing document, the Constitution of St Francis Leprosy Guild of 14 May 2020 which was updated on 3 December 2025.
## **Charity constitution**
The charity is a Charitable Incorporated Organisation that was established on 25 March 2020.
## **Charitable structure**
SFLG changed its charitable status from an Unincorporated Association to a Charitable Incorporated (Foundation) Organisation (CIO) on 25 March 2020.
## **Update to the CIO Constitution**
On 3 December 2025, a resolution to amend the Constitution was agreed by the trustees and, along with an amended version of the Constitution, was posted to the Charity Commission website. The Constitution was amended to change the location of the registered office and to amend the provisions which had previously required the Custos of the Orders of Friars Minor to be an ex officio trustee.
## **Appointment of trustees**
Under SFLG's constitution, up to twelve trustees may be appointed for up to three terms of three years but may not be reappointed for a fourth term until after an interval of at least one year. Trustees are appointed based on suitable qualifications and experience. They are briefed on the activities of SFLG and their responsibilities as trustees by the existing trustees and the Executive team. They manage the affairs of the CIO and exercise individually and jointly the powers set out in the Constitution. CBCEW nominates a trustee to represent them.
In 2025, four trustees retired or stood down from the Board: Liam Allmark, Caroline ConnollyNewland (Treasurer), Dr William Dibb, and Sandra Pearce, to deal with competing professional and personal commitments. SFLG is very grateful for their valuable contribution. In 2025, Fr Gary Dench joined the Board as a trustee and Spiritual Director, Molly Conrad joined the Board as a trustee and CBCEW representative, and Dr Aodhán Breathnach joined the Board as a trustee.
The trustees' skills audit is up to date.
All trustees give their time freely and no trustee remuneration was paid in the year. Details of trustee expenses and related transactions are disclosed in the notes to the accounts. Trustees are required to disclose all relevant interests at each meeting.
19
St Francis Leprosy Guild Annual Report 2025
## **Trustees' responsibility statement**
The trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland.
The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2008 and the provisions of the Constitution of SFLG require the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently
- observe the methods and principles in the Charity SORP
- make judgements and estimates that are reasonable and prudent
- state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements
- prepare the financial statements on the going-concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the governing document. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the charity and financial information included on the charity's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Approved by order of the Board of Trustees on …………………………………… signed on its behalf by:
………………………………………………………………………………. **Edward Reed, Chair**
20
St Francis Leprosy Guild Annual Review 2025
## **Independent examiner's report to the trustees of St Francis Leprosy Guild**
I report to the charity trustees on my examination of the accounts of St Francis Leprosy Guild (the Trust) for the year ended 31 December 2025.
## **Responsibilities and basis of report**
As the charity trustees of the Trust, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
## **Independent examiner's statement**
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a registered member of ICAEW which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report to enable a proper understanding of the accounts to be reached.
Paul West Paul West (Jul 28, 2026 15:12:11 GMT+1)
## **Paul West FCA**
## **PKW Accountants Limited**
## **Second Floor, 1 Church Square, Leighton Buzzard, Bedfordshire, LU71AE**
## Date: Jul 28, 2026 ……………………………………………………...
21
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **STATEMENT OF FINANCIAL ACTIVITIES AND INCOME AND EXPENDITURE**
## **FOR THE YEAR ENDED 31 DECEMBER 2025**
|Note
**INCOME AND ENDOWMENTS**
Incoming resources from generated funds
Donations and legacies
3
Investments
4
Total Incoming Resources
**EXPENDITURE**
Raising Funds
5
Charitable activities
6
Total Resources Expended
**NET (EXPENDITURE) INCOME FOR THE YEAR**
**OTHER RECOGNISED GAIN**
Other gains/(losses)
**NET MOVEMENT IN FUNDS**
**RECONCILIATION OF FUNDS**
Total funds brought forward
**Total funds carried forward**|Unrestricted
Funds
236,550
651
237,201
231,803
358,597
590,400|Restricted
Funds
0
0
0
0
0
0
0
0
0
0|Total Funds
2025
236,550
651
237,201
231,803
358,597
590,400
-353,199
74,889
-278,310
703,494
425,184|Total Funds
2024
373,354
2,161|
|---|---|---|---|---|
|||||375,515|
|||||261,734
384,003|
|||||645,737|
||||||
||-353,199|||-270,222|
||74,889
-278,310
703,494
425,184|||59,339|
|||||-210,883
914,173|
|||||703,290|
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 24-29 form part of these financial statements.
22
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **STATEMENT OF FINANCIAL POSITION (BALANCE SHEET) AS AT 31 DECEMBER 2025**
|Note
**FIXED ASSETS**
Tangible assets
7
Investments
8
**CURRENT ASSETS**
Debtors
9
Cash at bank
**CREDITORS: amounts falling due**
**within one year**
10
**NET CURRENT ASSETS**
**NET ASSETS**
**THE FUNDS OF THE CHARITY**
**TOTAL CHARITY FUNDS**
11|Unrestricted
Funds
0
462,799
462,799
2,215
25,579
27,794
-65,409
-37,615
425,184
425,184|Restricted
Funds
0
0
0
0
0
0
0
0
0|Total
2025
0
462,799
462,799
2,215
25,579
27,794
-65,409
-37,615
425,184
425,184|Total
2024
0
637,981|
|---|---|---|---|---|
|||||637,981
1,694
92,387|
|||||94,081
-28,772|
|||||65,309|
|||||703,290|
|||||703,290|
The notes on pages 26-31 form part of these financial statements.
Signed on behalf of
the Board of Trustees
Edward Reed Chair of Trustees Approved by the Trustees on
23
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## 1. **GENERAL INFORMATION**
St Francis Leprosy Guild is a Charitable Incorporated Organisation, charity number 1188749.
The address of the registered office is 51 High Street, Arundel, West Sussex BN18 9AJ.
The previous address of 73 St Charles Square, London W10 6EJ was closed in March 2025.
## 2. **ACCOUNTING POLICIES**
## **Accounting conventions and basis of preparation**
The accounts have been prepared in accordance with the Trust's governing document as well as:
(a) FRS102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with Financial Reporting Standard in the UK and Republic of Ireland (FRS102) (Charities SORP (FRS102))
(b) The Charities Act 2011
(c) the historic cost basis of accounting, as modified by the revaluation of certain financial assets and liabilities measured at fair value through income and expenditure.
The financial statements are prepared in Sterling which is the functional currency of the entity.
## **Fund accounting**
Unrestricted funds are available for use at the discretion of the Trustees in furtherance of the
general objectives of the charity.
Restricted funds are subjected to restrictions on their expenditure imposed by the donor or through
the terms of an appeal. There are no restricted funds currently in the charity.
## **Incoming resources**
All incoming resources are included in the Statement of Financial Activities when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income:
- Voluntary income is received by way of donations, gifts and grants and is included in full in
the Statement of Financial Activities. Grants where entitlement is not conditional on the delivery
of a specific performance of the charity are recognised when the charity becomes
unconditionally entitled to the grant.
- Investment income is included when receivable.
- No amounts are included in the financial statements for services donated by volunteers.
## **Resources expended**
All expenditure is accounted for on an accrual basis. Expenditure includes any VAT which cannot be recovered, and is reported as part of the expenditure to which it relates. The following specific policies are applied to particular categories of expenditure:
- Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated
directly to such activities and those costs of an indirect nature necessary to support them.
- Governance costs include those costs associated with meeting the constitutional and statutory requirements of the charity and include the audit fees and costs linked to the strategic management of the charity.
Governance and support costs have been allocated on a 50:50 basis between raising funds and grant allocations. The support costs for grant allocations are allocated on a grant payable basis.
## **Cash flow**
As a small reporting entity, is exempt from the requirements to prepare such a statement under Financial Reporting Standard 'Cash flow statements'.
24
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## 2. **ACCOUNTING POLICIES (continued)**
## **Tax recoverable**
Tax recoverable relating to Gift Aid income is taken into account in the year in which the donation is received.
## **Valuation of investments**
Investments held as fixed assets are shown at current valuation.
## **Going concern**
There are no material uncertainties about the charity's ability to continue.
## **Judgements and key sources of estimation uncertainty**
The preparation of the financial statements requires management to make judgements, estimates, and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Accounting estimates and assumptions are made concerning the future and, by their very nature will rarely equal the related actual outcome.
## **Financial instruments**
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a
financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
25
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## 3. **DONATIONS AND LEGACIES**
|4.
5.|Donations and gifts
Legacies receivable
Gift Aid
Total charitable activities
**INVESTMENTS**
Income from listed investments
Interest receivable
**RAISING FUNDS**
Fundraising and publicity
Marketing
Online costs
Depreciation
Support costs
Investment management
Raising Funds total
Investment management
Investment charges|Unrestricted
Funds
146,705
67,812
22,033
236,550|Restricted
Funds
0
0
0
0|Total Funds
2025
146,705
67,812
22,033
236,550|Total Funds
2024
254,980
97,967
20,407|
|---|---|---|---|---|---|
|||||||
||||||373,354|
|||||2025
-
651
651
2025
123,810
13,543
-
94,378
231,731
72
231,803
72
72|2024
-
2,161|
||||||2,161|
||||||2024
124,635
1,255
200
115,436|
||||||241,526|
||||||20,208
261,734|
||||||20,208|
||||||20,208|
Note: there was both a significant fee cost in 2024 due to exiting Brewin Dolphin,
as well as a notable change in how W1M's fees are paid this year.
26
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## **6. RESOURCES EXPENDED - CHARITABLE ACTIVITIES**
|Activities undertaken directly
TRACE acronym
Grant funding of activities
Share of support and governance
costs
Total charitable activities|Trainin
g
Research
Active Case
Care
Emergency/
Total
Total
Funds
Funds
Finding
grants
Capital grants
2025
2024
( T )
( R )
( A )
( C )
( E )
-
60,000
45,000
155,820
3,400
264,220
268,567
-
21,431
16,074
55,657
1,214
94,377
115,436|
|---|---|
||-
81,431
61,074
211,477
4,614
358,597
384,003|
## **RESOURCES EXPENDED - GOVERNANCE AND SUPPORT COSTS**
|**Support**
Staff costs
Consultancy
Rent, utilities and telephone
Postage and stationery
IT support costs
Insurance
Travelling and events
Training
Bank charges
Subscriptions
Office move
Records management
Sundries
Professional fees
**Governance**
Legal advice
Independent examination services
Trustees expenses
Total
**Analysed between**
Fundraising
Charitable activities|Unrestricted
Restricted
Total Funds
Total Funds
Funds
Funds
2025
2024
76,318
76,318
69,706
54,134
54,134
55,500
1,118
1,118
8,161
1,587
1,587
1,947
5,315
5,315
43,103
2,181
2,181
2,114
12,561
12,561
7,283
269
269
319
805
805
944
6,979
6,979
8,656
3,949
3,949
-
3,349
3,349
-
875
875
769
18,295
18,295
28,326|
|---|---|
||187,735
0
187,735
226,828|
||Unrestricted
Restricted
Funds
Funds
Total Funds
Total Funds
2,025
2,024
-
-
-
1,950
1,020
-
1,020
2,094
-
-
-
-|
||1,020
-
1,020
4,044|
|||
||188,755
-
188,755
230,872|
||94,378
-
94,378
115,436
94,377
-
94,377
115,436|
27
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## 7. **TANGIBLE ASSETS**
|Cost at 1/1/2025 and 31/12/2025
Depreciation at 1/1/2025
Depreciation charge for the year
Depreciation at 31/12/2025
NBV at 31/12/2025
NBV at 31/12/2024
8.
**INVESTMENTS VALUATION**
Market Value at 1 January 2025
Additions
Disposals
Charges
Net realised investment gain/(loss)
Market Value at 31 December 2025
Waverton changed its name to W1M in 2025.|Equipment
9229
9229
0
9229
0
0|Total
9229|
|---|---|---|
|||9229
0|
|||9229|
|||0
0
Total
637,981
-
-250,000
-72
74,890|
|||462,799|
||||
The Charity’s investment policy is to maximise income, whilst protecting the capital value of any investments.
|9.
**DEBTORS**
Prepayments
Gift Aid
10.
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Accruals
Trade creditors
Other taxation and social security
11.
**ANALYSIS OF NET ASSETS BETWEEN FUNDS**|2025
-
2,215
2,215
2025
58,586
6,823
-
65,409|2024
0
1,694|
|---|---|---|
|||1,694|
|||2024
13,618
15,154
-|
|||28,772|
||||
|Investments
Net current assets|Unrestricted
funds
462,799
-37,615
425,184|Restricted
funds
-
-
-|Total
funds
462,799
-37,615
425,184|2024
637,981
65,309
703,290|
|---|---|---|---|---|
28
St Francis Leprosy Guild Annual Review 2025
## **ST FRANCIS LEPROSY GUILD**
## **SUNDRY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025**
## 12. **RETIREMENT BENEFIT SCHEMES**
## Defined contribution scheme
The Trust operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Trust in an independently administered fund. The charge to the Financial Activity report in respect of defined contribution schemes was £1,878 (2024 - £1.758).
## 13. **DESIGNATED FUNDS**
There are no funds currently under designation.
## 14. **RELATED PARTY TRANSACTIONS**
There were no disclosable related party transactions during the year (2024 - none).
## 15. **TRUSTEES**
None of the trustees (or any persons connected with them) received any remuneration or benefits from the Trust during the year.
There were no trustee expenses incurred in the year (2024 - none).
## 16.
## **EMPLOYEES**
|The average monthly number of employees during the year was:
**Employment costs**
Wages and salaries
Other pension costs
Redundancy costs|2025
2024|
|---|---|
||2
2|
||2025
2024
74,440
67,948
1,878
1,758
-
-|
||76,318
69,706|
The charity considers its key management personnel comprises the trustees and the Director. The Director is not employed directly, therefore there is no key management personnel remuneration to report (2024 - £nil), or pension contributions (2024 - £nil), or employers' national insurance (2024 - £nil).
|The number of employees whose annual remuneration
was more than £60,000 is as follows:|2025
2024|
|---|---|
||0
0|
29
## SFLG Annual Report & Accounts 2025 -version 10.7.26 signed by Edward Reed
Final Audit Report
2026-07-28
Created: 2026-07-28 By: Edmund Chavasse (edmund@waughaccountants.co.uk) Status: Signed Transaction ID: CBJCHBCAABAA200AaPGi3d4MhI8Q_3mHVdFoHboeff7U
## "SFLG Annual Report & Accounts 2025 -version 10.7.26 signed by Edward Reed" History
Document created by Edmund Chavasse (edmund@waughaccountants.co.uk)
2026-07-28 - 9:50:25 AM GMT
- Document emailed to paul.west@pkwassociates.co.uk for signature
2026-07-28 - 9:51:02 AM GMT
Email viewed by paul.west@pkwassociates.co.uk
2026-07-28 - 9:51:20 AM GMT
Signer paul.west@pkwassociates.co.uk entered name at signing as Paul West
- 2026-07-28 - 2:12:09 PM GMT
## Document e-signed by Paul West (paul.west@pkwassociates.co.uk)
Signature Date: 2026-07-28 - 2:12:11 PM GMT - Time Source: server - Signature Appearance Selected: TYPE
Agreement completed.
2026-07-28 - 2:12:11 PM GMT